Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are eight patents…
Source
Annual Drug Patent Expirations for VELTASSA Veltassa is a drug marketed by Vifor Pharma and is included in one NDA. It is available from one supplier. There are thirteen patents…
Source
New patent expiration for Vifor Pharma drug VELTASSA Read Post »
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
This chart shows the drugs with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Japan? Read Post »
Annual Drug Patent Expirations for FORTEO Forteo is a drug marketed by Lilly and is included in one NDA. It is available from two suppliers. There is one patent protecting…
Source
This chart shows the patent expirations for cream dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
Source
Annual Drug Patent Expirations for ADVIL+DUAL+ACTION+WITH+ACETAMINOPHEN Advil Dual Action With Acetaminophen is a drug marketed by Haleon Us Holdings and is included in one NDA. It is available from two…
Source
New patent for Haleon Us drug ADVIL DUAL ACTION WITH ACETAMINOPHEN Read Post »
Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
Source
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the greatest global patent coverage? Read Post »
VELTASSA (patiromer sorbitex calcium) Vifor pharma Patent: 8,889,115 Expiration: Mar 30, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
Source
Drug Patent Expirations for the Week of March 24, 2024 Read Post »
Get new actionable insights and updates from BiotechBlog
